Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group
Antineoplastic Combined Chemotherapy Protocols
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Prospective analysis of the role of multiple drug resistance in localized osteosarcoma did not find that immunohistochemical analysis of P-gp expression predicted outcome for patients treated on INT0133.